88 related articles for article (PubMed ID: 10361185)
41. Ghrelin reduction after esophageal substitution and its correlation to postoperative body weight loss in esophageal cancer patients.
Doki Y; Takachi K; Ishikawa O; Miyashiro I; Sasaki Y; Ohigashi H; Nakajima H; Hosoda H; Kangawa K; Sasakuma F; Motoori M; Imaoka S
Surgery; 2006 Jun; 139(6):797-805. PubMed ID: 16782437
[TBL] [Abstract][Full Text] [Related]
42. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
43. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
[TBL] [Abstract][Full Text] [Related]
44. Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome.
de Mello VD; Kolehmainen M; Schwab U; Mager U; Laaksonen DE; Pulkkinen L; Niskanen L; Gylling H; Atalay M; Rauramaa R; Uusitupa M
Metabolism; 2008 Feb; 57(2):192-9. PubMed ID: 18191048
[TBL] [Abstract][Full Text] [Related]
45. Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy.
Mantovani G; Maccio A; Madeddu C; Massa E; Mudu MC; Mulas C; Gramignano G; Massidda S; Murgia V; Lusso MR; Mura L
Int J Oncol; 2001 Feb; 18(2):383-91. PubMed ID: 11172608
[TBL] [Abstract][Full Text] [Related]
46. Reduction in fat intake is not associated with weight loss in most women after breast cancer diagnosis: evidence from a randomized controlled trial.
Rock CL; Thomson C; Caan BJ; Flatt SW; Newman V; Ritenbaugh C; Marshall JR; Hollenbach KA; Stefanick ML; Pierce JP
Cancer; 2001 Jan; 91(1):25-34. PubMed ID: 11148556
[TBL] [Abstract][Full Text] [Related]
47. [Diagnosis and treatment of colorectal liver metastases - workflow].
Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
[TBL] [Abstract][Full Text] [Related]
48. Changes of ghrelin and leptin in response to hypocaloric diet in obese patients.
de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O
Nutrition; 2008 Feb; 24(2):162-6. PubMed ID: 18165128
[TBL] [Abstract][Full Text] [Related]
49. The extent of resection influences outcome following hepatectomy for colorectal liver metastases.
Stewart GD; O'Súilleabháin CB; Madhavan KK; Wigmore SJ; Parks RW; Garden OJ
Eur J Surg Oncol; 2004 May; 30(4):370-6. PubMed ID: 15063889
[TBL] [Abstract][Full Text] [Related]
50. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
[TBL] [Abstract][Full Text] [Related]
51. Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients.
O'Gorman P; McMillan DC; McArdle CS
Nutr Cancer; 1998; 32(2):76-80. PubMed ID: 9919615
[TBL] [Abstract][Full Text] [Related]
52. Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer.
O'Gorman P; McMillan DC; McArdle CS
Nutr Cancer; 1999; 35(2):127-9. PubMed ID: 10693165
[TBL] [Abstract][Full Text] [Related]
53. A randomized study of nutritional support in patients with colorectal and gastric cancer.
Persson CR; Johansson BB; Sjöden PO; Glimelius BL
Nutr Cancer; 2002; 42(1):48-58. PubMed ID: 12235650
[TBL] [Abstract][Full Text] [Related]
54. Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer.
Huang A; Fuchs D; Widner B; Glover C; Henderson DC; Allen-Mersh TG
Br J Cancer; 2002 Jun; 86(11):1691-6. PubMed ID: 12087451
[TBL] [Abstract][Full Text] [Related]
55. Malignant metastatic tumours in the liver: an African series.
Olubuyide IO; Odunfa OA
Trop Gastroenterol; 1989; 10(3):148-52. PubMed ID: 2815322
[TBL] [Abstract][Full Text] [Related]
56. Relation between depression and circulating immune products in patients with advanced colorectal cancer.
Allen-Mersh TG; Glover C; Fordy C; Henderson DC; Davies M
J R Soc Med; 1998 Aug; 91(8):408-13. PubMed ID: 9816354
[TBL] [Abstract][Full Text] [Related]
57. Appearance-specific satiety increases appetite and quality of life in patients with metastatic liver tumor: a case report.
Kawaguchi T; Taniguchi E; Itou M; Akiyoshi J; Itano S; Otsuka M; Iwasaki S; Matsuda T; Ibi R; Shiraishi S; Oriishi T; Tanaka S; Saruwatari Y; Sata M
Kurume Med J; 2006; 53(1-2):41-6. PubMed ID: 17043395
[TBL] [Abstract][Full Text] [Related]
58. Unintentional Weight Loss in Older Adults.
Gaddey HL; Holder KK
Am Fam Physician; 2021 Jul; 104(1):34-40. PubMed ID: 34264616
[TBL] [Abstract][Full Text] [Related]
59. Weight loss programs. Is one right for you?
Shuman JM
Nursing; 1993 May; 23(5):70, 73. PubMed ID: 8488000
[No Abstract] [Full Text] [Related]
60. The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer.
Fearon KC
Proc Nutr Soc; 1992 Aug; 51(2):251-65. PubMed ID: 1438334
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
